Antipsychotics and the risk of venous thromboembolism

BMJ (Online)

Volumn 341, Issue 7774, 2010, Pages 613-

  Liperoti, Rosa ^a   Gambassi, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTICOAGULANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARDIOLIPIN ANTIBODY; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; GLUCOSE; HALOPERIDOL; LEPTIN; LUPUS ANTICOAGULANT; NEUROLEPTIC AGENT; PROCHLORPERAZINE; QUETIAPINE; THIORIDAZINE; TRIFLUOPERAZINE;

BLOOD CLOTTING; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DEMENTIA; DRUG POTENCY; DYSLIPIDEMIA; EDITORIAL; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MENTAL PATIENT; MORTALITY; NAUSEA AND VOMITING; PRIORITY JOURNAL; SCHIZOPHRENIA; SEDATION; THROMBOCYTE AGGREGATION; VENOUS THROMBOEMBOLISM; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; HUMANS; RISK FACTORS; SCHIZOPHRENIA; VENOUS THROMBOEMBOLISM;

EID: 77957107476     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c4216     Document Type: Editorial

References (12)

1. Hägg S, Jönsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf 2009;8:537-47. [CrossRef] [Medline] [Web of Science]
2. Paciullo CA. Evaluating the association between clozapine and venous thromboembolism. Am J Health Syst Pharm 2008;65:1825-9. [Abstract/FREE Full text]
3. Jönsson AK, Horváth-Puhó E, Hägg S, Pedersen L, Sørensen HT. Antipsychotics and risk of venous thromboembolism: a population-based case-control study. Clin Epidemiol 2009;1:19-26.
4. Hindersin P, Siegmund R, Körting HJ. Thrombophilic diatheses as hemostasis disorders in acute psychoses. Psychiatr Neurol Med Psychol (Leipz) 1984;36:702-9. [Medline]
5. Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and the risk of venous thromboembolism: nested case-control study. BMJ 2010;341:c4245. [Abstract/FREE Full text]
6. Chaggar PS, Shaw SM, Williams SG. Effect of antipsychotic medications on glucose and lipid levels. J Clin Pharmacol 2010 published online 21 April.
7. Canoso RT, de Oliveira RM, Nixon RA. Neuroleptic-associated autoantibodies. A prevalence study. Biol Psychiatry 1990;27:863-70. [CrossRef] [Medline] [Web of Science]
8. Orr MW, Knox JM, Allen R, Gelder MG, Grahame-Smith DG. The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients. Br J Clin Pharmacol 1981;11:255-9. [Medline] [Web of Science]
9. Axelsson S, Hagg S, Eriksson AC, Lindhal TL, Whiss PA. In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation. Clin Exp Pharmacol Physiol 2007;34:775-80. [CrossRef] [Medline] [Web of Science] (Pubitemid 47013497)
10. Oruch R, Hodneland E, Pryme IF, Holmsen H. In thrombin stimulated human platelets citalopram, promethazine, risperidone, and ziprasidone, but not diazepam, may exert their pharmacological effect through intercalation in membrane phospholipids in a receptor-independent manner. J Chem Biol 2009;2:89-103. [CrossRef] [Medline]
11. Tapson VF. Acute pulmonary embolism. N Engl J Med 2008;358:1037-52. [CrossRef] [Medline] [Web of Science]
12. Kuehn BM. Questionable antipsychotic prescribing remains common, despite serious risks. JAMA 2010;303:1582-4. [FREE Full text]